Literature DB >> 24202580

Models of environmentally induced neurological disease: epidemiology and etiology of amyotrophic lateral sclerosis and parkinsonism-dementia in the Western Pacific.

R M Garruto1, R Yanagihara, D C Gajdusek.   

Abstract

Amyotrophic lateral sclerosis (ALS) on Guam previously attained incidence rates 50 to 100 times that of the continental United States and Europe and accounted for one in five deaths among Chamorros over age 25. A second neurological disorder in high incidence, parkinsonism-dementia (PD), and the early appearance in those populations of neurofibrillary tangles such as are seen in Alzheimer's disease and normal ageing have also been noted. Incidence and mortality rates of both diseases have declined dramatically during the past 30 years, and today, the risk of developing either disease among Guamanian Chamorros is only several times higher than in non-Guamanian populations. The decline is most likely a consequence of increased acculturation over the past three decades, with a concomitant decrease in isolation, changes in dietary habits and local water supplies, and much less dependence on locally grown foodstuffs. Similar declines are evident in the remaining two Pacific foci of high- incidence ALS, namely the Kii Peninsula focus in Japan and southern West New Guinea where western contact and introduction of new foodstuffs have occurred.The accumulating epidemiological, genetic and environmental evidence, as well as the development of new and promising experimental animal models, support the hypothesis that a basic metabolic defect, provoked by chronic nutritional deficiencies of calcium, lead to increased intestinal absorption of toxic metals and the co-deposition of calcium, aluminium and silicon in neurons of patients with ALS and PD. This elemental deposition is thought to result in aberrant microtubule assembly and/or abnormal post-translational modification of the amyloid precursor protein leading to widespread formation of neurofibrillary tangles, the hallmark pathological features in these disorders. The naturalistic paradigms of these foci in the Western Pacific have provided insights to understanding not only ALS and PD but other neurological disorders, such as classical ALS, Parkinson's disease, Alzheimer's disease and early neuronal ageing.

Entities:  

Year:  1990        PMID: 24202580     DOI: 10.1007/BF01734063

Source DB:  PubMed          Journal:  Environ Geochem Health        ISSN: 0269-4042            Impact factor:   4.609


  73 in total

1.  CYCAD TOXICITY IN MONKEYS: CLINICAL, PATHOLOGICAL, AND BIOCHEMICAL ASPECTS.

Authors:  D K DASTUR
Journal:  Fed Proc       Date:  1964 Nov-Dec

2.  Cycad flour used by Guamanians: effects produced in rats by long-term feeding.

Authors:  M G Yang; O Mickelsen; M E Campbell; G L Laqueur; J C Keresztesy
Journal:  J Nutr       Date:  1966-10       Impact factor: 4.798

3.  Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea.

Authors:  D C Gajdusek; A M Salazar
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

4.  Virus detection by nucleic acid hybridization: examination of normal and ALS tissues for the presence of poliovirus.

Authors:  D E Kohne; C J Gibbs; L White; S M Tracy; W Meinke; R A Smith
Journal:  J Gen Virol       Date:  1981-10       Impact factor: 3.891

5.  An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, parkinsonism dementia, and Parkinson's disease.

Authors:  C J Gibbs; D C Gajdusek
Journal:  Adv Neurol       Date:  1982

6.  Bone mass in Guamanian patients with amyotrophic lateral sclerosis and parkinsonism-dementia.

Authors:  R M Garruto; C C Plato; R Yanagihara; K Fox; J Dutt; D C Gajdusek; J Tobin
Journal:  Am J Phys Anthropol       Date:  1989-09       Impact factor: 2.868

7.  Cellular and molecular mechanisms of neuronal degeneration: Amyotrophic lateral sclerosis, parkinsonism-demantia, and Alzheimer disease.

Authors:  Ralph M Garruto
Journal:  Am J Hum Biol       Date:  1989       Impact factor: 1.937

8.  Cortical bone loss and measurements of the second metacarpal bone: II. Hypodense bone in postwar Guamanian children.

Authors:  C C Plato; W W Greulich; R M Garruto; R Yanagihara
Journal:  Am J Phys Anthropol       Date:  1984-01       Impact factor: 2.868

9.  Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam.

Authors:  R M Garruto; R Fukatsu; R Yanagihara; D C Gajdusek; G Hook; C E Fiori
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  Calcium and vitamin D metabolism in Guamanian Chamorros with amyotrophic lateral sclerosis and parkinsonism-dementia.

Authors:  R Yanagihara; R M Garruto; D C Gajdusek; A Tomita; T Uchikawa; Y Konagaya; K M Chen; I Sobue; C C Plato; C J Gibbs
Journal:  Ann Neurol       Date:  1984-01       Impact factor: 10.422

View more
  4 in total

1.  Review of epidemiologic studies of aluminium and neurological disorders.

Authors:  G F Craun
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

2.  Aluminium and Alzheimer's disease: is there a causal connection?

Authors:  T Houeland
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

3.  Therapeutic effect of the combined use of growth hormone releasing peptide-6 and epidermal growth factor in an axonopathy model.

Authors:  Diana García Del Barco; Héctor Pérez-Saad; Valia Rodríguez; Javier Marín; Viviana Falcón; Jorge Martín; Danay Cibrian; Jorge Berlanga
Journal:  Neurotox Res       Date:  2010-02-19       Impact factor: 3.911

4.  Alzheimer's Disease and its Related Dementias among Asian Americans, Native Hawaiians, and Pacific Islanders: A Scoping Review.

Authors:  Sahnah Lim; Sadia Mohaimin; Deborah Min; Timothy Roberts; Young-Jin Sohn; Jazmine Wong; Ragavan Sivanesathurai; Simona C Kwon; Chau Trinh-Shevrin
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.